Search

Displaying results 701 - 710 of 10000 in total
  1. Indication

    Burning sensation in the mouth

    go.drugbank.com/conditions/DBCOND0102063
    Drugs: Benzoic acid
    Synonyms: Discomfort in mouth, Burning sensation in the mouth
  2. Indication

    Deficiencies in enzymes of the urea cycle

    go.drugbank.com/conditions/DBCOND0023710
    Drugs: Phenylbutyric acid
    Synonyms: Deficiencies in enzymes of the urea cycle
  3. Indication

    Squamous Cell Carcinoma In-situ (SCC-is)

    go.drugbank.com/conditions/DBCOND0043487
    Drugs: Aminolevulinic acid
    Synonyms: Squamous cell carcinoma in situ, no International Classification of Diseases for Oncology subtype, Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype
  4. Drug

    Betiatide

    go.drugbank.com/drugs/DB14082
    Approved

    Products: Renoscint MAG3 1 mg Kit für ein radioaktives Arzneimittel, Kit for the Preparation of Technetium Tc99m Mertiatide
  5. Drug

    Interferon alfa-2b

    go.drugbank.com/drugs/DB00105
    ApprovedInvestigational

    This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. … Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23.

    Mixtures: Rebetron Ready To Use Solution (albumin(human)free) (6000000 Iu/ml and 200mg Capsules)Categories: Interferon Type I
  6. Drug

    Ademetionine

    go.drugbank.com/drugs/DB00118
    ApprovedInvestigationalNutraceutical

    Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. … It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)

    Mixtures: HEPASELAMİN AMİNOASİT IV İNFÜZYON ÇÖZELTİSİ 500 ML SETLİ ŞİŞE, HEPASELAMİN AMİNOASİT IV İNFÜZYON ÇÖZELTİSİ 500 ML SETSİZ ŞİŞESynonyms: SAMe
  7. Drug

    Luspatercept

    go.drugbank.com/drugs/DB12281
    ApprovedInvestigational

    [A187829,L42455] It was first approved for use in the United States in November 2019 under the brand name Reblozyl® for the treatment of anemia in patients with beta thalassemia who require regular blood … [A187835] Luspatercept's novel mechanism of action, then, is uniquely suited for the treatment of conditions in which late-stage erythropoiesis is defective, such as beta thalassemia and other myelodysplastic

    Products: Reblozyl 25 mg powder for solution for injection, Reblozyl 75 mg powder for solution for injection
  8. Drug

    Fondaparinux

    go.drugbank.com/drugs/DB00569
    ApprovedInvestigational

    The monomeric sequence in heparin and HS is thought to form the high affinity binding site for the natural anti-coagulant factor, antithrombin III (ATIII). … Once bound to heparin or HS, the anticoagulant activity of ATIII is potentiated by 1000-fold. Fondaparinux potentiates the neutralizing action of ATIII on activated Factor X 300-fold.

    Products: ARIXTRA 12.5MG/ML SOLUTION FOR INJECTION, ARIXTRA 2.5MG/0.5ML SOLUTION FOR INJECTION
  9. Drug

    Trimebutine

    go.drugbank.com/drugs/DB09089
    ApprovedInvestigational

    It is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. … Trimebutine is not a FDA-approved drug, but it is available in Canada and several other international countries.

    Categories: Drugs for Functional Gastrointestinal DisordersInternational brands: Ni Wei Fu, Puridat Fort
  10. Drug

    Conivaptan

    go.drugbank.com/drugs/DB00872
    Approved

    It was approved in 2004 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH). … Conivaptan is a non-peptide inhibitor of antidiuretic hormone (vasopressin).

    Products: Vaprisol Dextrose In Plastic Container